Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization.

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{55c7e81c6b924ea29e5399de1ed1e196,

title = "Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization.",

author = "Raghavender Boothpur and Stephanie Torrence and Brennan, \{Daniel C.\}",

year = "2009",

language = "English (US)",

pages = "491--493",

journal = "Clinical transplants",

issn = "0890-9016",

publisher = "UCLA Tissue Typing Laboratory",

}

TY - JOUR

T1 - Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization.

AU - Boothpur, Raghavender

AU - Torrence, Stephanie

AU - Brennan, Daniel C.

PY - 2009

Y1 - 2009

UR - https://www.scopus.com/pages/publications/77954578418

UR - https://www.scopus.com/pages/publications/77954578418#tab=citedBy

M3 - Article

C2 - 20524321

AN - SCOPUS:77954578418

SN - 0890-9016

SP - 491

EP - 493

JO - Clinical transplants

JF - Clinical transplants

ER -